Unknown OBSERVATIONAL NCT04962386

Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD

Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With Meibomian Gland Dysfunction

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Interventions Hormone replacement therapy

Updated 5 times since 2021 Last updated: Sep 9, 2021 Started: Mar 6, 2019 Primary completion: Mar 6, 2022 Completion: Mar 6, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04962386, this observational or N/A phase trial focuses on Meibomian Gland Dysfunction and remains ongoing. Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Oct 2021 — Jul 2023 [monthly]

Recruiting
Sep 2021 — Oct 2021 [monthly]

Recruiting

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Data source: Second Affiliated Hospital, School of Medicine, Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China